Max Robotics — Global Service Robot Directory + US Certification

About

Fahed Fayad is a radiation oncologist whose research has made significant contributions to the field of stereotactic radiosurgery, particularly in the treatment of lung cancer using robotic radiotherapy systems. His work has centered on the application of CyberKnife® technology — an image-guided robotic radiosurgery platform — to both primary and metastatic lung tumors, establishing its efficacy as a non-invasive alternative for patients deemed medically inoperable. Fayad's most influential study, "CyberKnife® Radiosurgery for Stage I Lung Cancer: Results at 36 Months" (2007), has garnered 86 citations and helped validate robotic radiosurgery as a viable curative option for early-stage non-small cell lung cancer (NSCLC). His subsequent work on lung metastases treated at 41 months (55 citations) and peripheral NSCLC applications (61 citations) further solidified the clinical case for this technology across diverse patient populations. Collectively, his publications have accumulated over 240 citations, reflecting a meaningful influence on treatment protocols in thoracic oncology. His later feasibility study exploring individualized high-dose five-fraction regimens demonstrates a continued commitment to optimizing therapeutic precision and expanding the boundaries of stereotactic radiotherapy.